Both in Biotechnology
Agenus vs Fennec Pharmaceuticals
Over the past year AGEN returned +46.7% and FENC returned +21.2%; their daily moves had a correlation of 0.18.
AGEN +46.7% FENC +21.2%Growth of $1, one year, split-adjusted
| Metric | AGEN | FENC |
|---|---|---|
| Price | $6.49 | $10.50 |
| Market cap | $292.9M | $368.2M |
| Today | +4.94% | +2.24% |
| 1 month | −22.1% | −3.8% |
| 6 months | +65.9% | +60.6% |
| Year to date | +106.5% | +36.4% |
| 1 year | +67.1% | +27.4% |
| Revenue growth (YoY) | +34.4% | +85.2% |
| Gross margin | 100.0% | 96.0% |
| Net margin | −1.7% | 11.0% |
| P/E (TTM) | 3.2× | — |
| Price / sales | 2.2× | 6.2× |
| Net cash | -$11.3M | $41.2M |
| Dividend yield | — | — |
| Volatility (60d) | 97.6% | 57.9% |
| Short % of float | 16.1% | 2.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).